To the Editor IL-17, an important prognostic factor and potential therapeutic target for breast cancer?

Enrichment of regulatory T cells in invasive breast tumor correlates with the upregulation of IL-17A expression and invasiveness of the tumor

(2013) Luciana Benevides et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Interleukin-17-producing cell infiltration in the breast cancer tumour microenvironment is a poor prognostic factor

(2013) Wen-Chung Chen et al.   HISTOPATHOLOGY

Small molecule inhibitors of RORγt: Targeting Th17 cells and other applications

(2012) Jun R. Huh et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Association Analysis of IL-17A and IL-17F Polymorphisms in Chinese Han Women with Breast Cancer

(2012) Lihong Wang et al.   PLoS One

The Endothelin Axis Stimulates the Expression of Pro-Inflammatory Cytokines and Pro-Migratory Molecules in Breast Cancer

(2010) Ashley N. Jewell et al.   CANCER INVESTIGATION

Transforming Growth Factor   Subverts the Immune System into Directly Promoting Tumor Growth through Interleukin-17

(2008) J.-S. Nam et al.   CANCER RESEARCH